▲ Peaking
Health
🔮 Newsylist predicts: still trending tomorrow low confidence
This 29-year-old had a 'miserable' cyclosporiasis experience: 'You lose complete control'
4sources
4articles
2velocity
+0%since first seen
6h agofirst detected
Sources (4)
- Influencer Had to Stop Reviewing Food After Losing 17 Lbs. Due to Cyclosporiasis Diagnosis: ‘It Stopped My Whole Life’ AOL.com · 1d ago
- Food Influencer Had to Stop Work After Losing 17 Lbs. Due to Cyclosporiasis Diagnosis: ‘It Stopped My Whole Life’ People.com · 1d ago
- 'Never in a million years thought it would be me' Nashville foodie shares Cyclospora story WZTV · 1d ago
- This 29-year-old had a 'miserable' cyclosporiasis experience: 'You lose complete control' USA Today · 1d ago broke it first
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
↓ Cooling
Health
🔮 holds
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.
↑ Rising
Health
🔮 fades
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.
↑ Rising
Health
🔮 holds ✗
DNR Closes Additional Areas of Cunningham Falls State Park Following Second Beaver Attack
Two separate beaver attacks at Cunningham Falls State Park prompt additional closures in Maryland.
↓ Cooling
Health
🔮 fades
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.
◼ Archived
Health
🔮 holds ✗
Pesticide exposure linked to higher risk of ALS, research finds
New research links occupational pesticide exposure to a significantly heightened risk of motor neuron diseases like ALS.
◼ Archived
Health
🔮 fades ✓
Breast cancer checks missing most women under 50 who are at risk, says study
Study finds NHS breast cancer guidelines miss 95% of high‑risk women under 50, sparking calls for review.